Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 128, Issue 25
December 22 2016
Issue Cover

Table of Contents

BLOOD FLASHBACK

Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 1979;54(3):713-733.
View Articletitled, Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. <em>Blood</em>. 1979;54(3):<span class="related-article">713-733</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Pee no more? Urine light chains down the drain
Joseph Mikhael
View Articletitled, Pee no more? Urine light chains down the drain
INSIDE BLOOD COMMENTARY
Leukemias and bones: humanizing the niche in mice
Renata Stripecke
View Articletitled, Leukemias and bones: humanizing the niche in mice
INSIDE BLOOD COMMENTARY
Dying a fiery death: pyroptosis in MDS
Alison R. Walker
View Articletitled, Dying a fiery death: pyroptosis in MDS
INSIDE BLOOD COMMENTARY
Trouble in the niche? Send in a statin
Jane L. Liesveld
View Articletitled, Trouble in the niche? Send in a statin
INSIDE BLOOD COMMENTARY
A breath of fresh air for umbilical cord blood
Shannon L. McKinney-Freeman
View Articletitled, A breath of fresh air for umbilical cord blood

BLOOD FORUM

The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology
Clinical Trials & Observations
Allison A. King,Sara K. Vesely,Jessica Elwood,Joe Basso,Ken Carson,Lillian Sung
View Articletitled, The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology

BLOOD SPOTLIGHT

Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies
Clinical Trials & Observations
Jeffrey D. Cooney,Ricardo C. T. Aguiar
View Articletitled, Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies

HOW I TREAT

How I use anticoagulation in atrial fibrillation
Benjamin A. Steinberg
View Articletitled, How I use anticoagulation in atrial fibrillation

CLINICAL TRIALS AND OBSERVATIONS

Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
Clinical Trials & Observations
Christine E. Ryan,Bita Sahaf,Aaron C. Logan,Susan O’Brien,John C. Byrd,Peter Hillmen,Jennifer R. Brown,Martin J. S. Dyer,Anthony R. Mato,Michael J. Keating,Samantha Jaglowski,Fong Clow,Andrew R. Rezvani,Lori Styles,Steven E. Coutre,David B. Miklos
View Articletitled, Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
Supplemental data

IMMUNOBIOLOGY

Basophil tryptase mMCP-11 plays a crucial role in IgE-mediated, delayed-onset allergic inflammation in mice
Misako Iki,Kensei Tanaka,Hayato Deki,Mio Fujimaki,Shingo Sato,Soichiro Yoshikawa,Yoshinori Yamanishi,Hajime Karasuyama
View Articletitled, Basophil tryptase mMCP-11 plays a crucial role in IgE-mediated, delayed-onset allergic inflammation in mice
Supplemental data

LYMPHOID NEOPLASIA

MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma
Clinical Trials & Observations
Ya-Wei Qiang,Shiqiao Ye,Yu Chen,Amy F. Buros,Ricky Edmonson,Frits van Rhee,Bart Barlogie,Joshua Epstein,Gareth J. Morgan,Faith E. Davies
View Articletitled, MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma
Supplemental data
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
Clinical Trials & Observations
Bing Cui,Emanuela M. Ghia,Liguang Chen,Laura Z. Rassenti,Christopher DeBoever,George F. Widhopf, II,Jian Yu,Donna S. Neuberg,William G. Wierda,Kanti R. Rai,Neil E. Kay,Jennifer R. Brown,Jeffrey A. Jones,John G. Gribben,Kelly A. Frazer,Thomas J. Kipps
View Articletitled, High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
Supplemental data
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma
CME
Thomas Dejoie,Jill Corre,Helene Caillon,Cyrille Hulin,Aurore Perrot,Denis Caillot,Eileen Boyle,Marie-Lorraine Chretien,Jean Fontan,Karim Belhadj,Sabine Brechignac,Olivier Decaux,Laurent Voillat,Philippe Rodon,Olivier Fitoussi,Carla Araujo,Lotfi Benboubker,Charlotte Fontan,Mourad Tiab,Pascal Godmer,Odile Luycx,Olivier Allangba,Jean-Michel Pignon,Jean-Gabriel Fuzibet,Laurence Legros,Anne Marie Stoppa,Mamoun Dib,Brigitte Pegourie,Frederique Orsini-Piocelle,Lionel Karlin,Bertrand Arnulf,Murielle Roussel,Laurent Garderet,Mohamad Mohty,Nathalie Meuleman,Chantal Doyen,Pascal Lenain,Margaret Macro,Xavier Leleu,Thierry Facon,Philippe Moreau,Michel Attal,Herve Avet-Loiseau
View Articletitled, Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

MYELOID NEOPLASIA

Establishing human leukemia xenograft mouse models by implanting human bone marrow–like scaffold-based niches
Antonella Antonelli,Willy A. Noort,Jenny Jaques,Bauke de Boer,Regina de Jong-Korlaar,Annet Z. Brouwers-Vos,Linda Lubbers-Aalders,Jeroen F. van Velzen,Andries C. Bloem,Huipin Yuan,Joost D. de Bruijn,Gert J. Ossenkoppele,Anton C. M. Martens,Edo Vellenga,Richard W. J. Groen,Jan Jacob Schuringa
View Articletitled, Establishing human leukemia xenograft mouse models by implanting human bone marrow–like scaffold-based niches
Supplemental data
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Ashley A. Basiorka,Kathy L. McGraw,Erika A. Eksioglu,Xianghong Chen,Joseph Johnson,Ling Zhang,Qing Zhang,Brittany A. Irvine,Thomas Cluzeau,David A. Sallman,Eric Padron,Rami Komrokji,Lubomir Sokol,Rebecca C. Coll,Avril A. B. Robertson,Matthew A. Cooper,John L. Cleveland,Luke A. O’Neill,Sheng Wei,Alan F. List
View Articletitled, The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis
Francesca Lupo,Elena Tibaldi,Alessandro Matte,Alok K. Sharma,Anna Maria Brunati,Seth L. Alper,Carlo Zancanaro,Donatella Benati,Angela Siciliano,Mariarita Bertoldi,Francesca Zonta,Alexander Storch,Ruth H. Walker,Adrian Danek,Benedikt Bader,Andreas Hermann,Lucia De Franceschi
View Articletitled, A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis
Supplemental data

TRANSPLANTATION

Atorvastatin enhances endothelial cell function in posttransplant poor graft function
Min-Min Shi,Yuan Kong,Yang Song,Yu-Qian Sun,Yu Wang,Xiao-Hui Zhang,Lan-Ping Xu,Kai-Yan Liu,Xiao-Jun Huang
View Articletitled, Atorvastatin enhances endothelial cell function in posttransplant poor graft function
Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation
Omar S. Aljitawi,Soumen Paul,Avishek Ganguly,Tara L. Lin,Sid Ganguly,George Vielhauer,Maegan L. Capitano,Amy Cantilena,Brea Lipe,Jonathan D. Mahnken,Amanda Wise,Abigale Berry,Anurag K. Singh,Leyla Shune,Christopher Lominska,Sunil Abhyankar,Dennis Allin,Mary Laughlin,Joseph P. McGuirk,Hal E. Broxmeyer
View Articletitled, Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation
Supplemental data

BLOOD WORK

Hodgkin lymphoma mimicking lung abscess
Andrew E. Foderaro,John L. Reagan
View Articletitled, Hodgkin lymphoma mimicking lung abscess
A rare histologic variant of a common lymphoma
Sanam Loghavi,L. Jeffrey Medeiros
View Articletitled, A rare histologic variant of a common lymphoma

ERRATUM

Cervantes F, Vannucchi AM, Kiladjian J-J, et al. Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis. Blood. 2013;122(25):4047-4053.
View Articletitled, Cervantes F, Vannucchi AM, Kiladjian J-J, et al. Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis. <em>Blood</em>. 2013;122(25):4047-4053.

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Serum FLC measurements for monitoring MM
CME
View Articletitled, Serum FLC measurements for monitoring MM
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals